Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amanda B Spurdle

Showing results (171-180 of 398) with videos related to

Pageof 40
Sort By:
Breast Cancer Research : BCR|July 1, 2005
CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors: Australian Breast Cancer Family StudyJiun-Horng Chang, Dorota M Gertig, Xiaoqing Chen, et al.
Human Molecular Genetics|January 25, 2024
Challenges and approaches to calibrating patient phenotype as evidence for cancer gene variant classification under ACMG/AMP guidelinesCristina Fortuno, Kyriaki Michailidou, Michael Parsons, et al.
International Journal of Cancer|January 10, 2019
Targeted RNA-seq successfully identifies normal and pathogenic splicing events in breast/ovarian cancer susceptibility and Lynch syndrome genesRita D Brandão, Klaas Mensaert, Irene López-Perolio, et al.
Human Mutation|March 10, 2009
Classifying MLH1 and MSH2 variants using bioinformatic prediction, splicing assays, segregation, and tumor characteristicsSven Arnold, Daniel D Buchanan, Melissa Barker, et al.
Gynecologic Oncology|December 11, 2012
High-throughput interrogation of PIK3CA, PTEN, KRAS, FBXW7 and TP53 mutations in primary endometrial carcinomaDiego A Garcia-Dios, Diether Lambrechts, Lieve Coenegrachts, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 21, 2005
Common polymorphisms in ERCC2 (Xeroderma pigmentosum D) are not associated with breast cancer riskBettina Kuschel, Georgia Chenevix-Trench, Amanda B Spurdle, et al.
Breast Cancer Research : BCR|November 27, 2007
Identification of BRCA1 missense substitutions that confer partial functional activity: potential moderate risk variants?Paul K Lovelock, Amanda B Spurdle, Myth T S Mok, et al.
Gynecologic Oncology|August 21, 2017
Family history of cancer predicts endometrial cancer risk independently of Lynch Syndrome: Implications for genetic counsellingSharon E Johnatty, Yen Y Tan, Daniel D Buchanan, et al.
Plos One|March 18, 2025
A Swedish genome-wide haplotype association analysis identifies novel candidate loci associated with endometrial cancer riskElin Barnekow, Wen Liu, Emil Andersson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 19, 2007
Association between single-nucleotide polymorphisms in hormone metabolism and DNA repair genes and epithelial ovarian cancer: results from two Australian studies and an additional validation setJonathan Beesley, Susan J Jordan, Amanda B Spurdle, et al.
Pageof 40

Showing results (171-180 of 398) with videos related to

Sort By:
Pageof 40
Breast Cancer Research : BCR|July 1, 2005
CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors: Australian Breast Cancer Family StudyJiun-Horng Chang, Dorota M Gertig, Xiaoqing Chen, et al.
Human Molecular Genetics|January 25, 2024
Challenges and approaches to calibrating patient phenotype as evidence for cancer gene variant classification under ACMG/AMP guidelinesCristina Fortuno, Kyriaki Michailidou, Michael Parsons, et al.
International Journal of Cancer|January 10, 2019
Targeted RNA-seq successfully identifies normal and pathogenic splicing events in breast/ovarian cancer susceptibility and Lynch syndrome genesRita D Brandão, Klaas Mensaert, Irene López-Perolio, et al.
Human Mutation|March 10, 2009
Classifying MLH1 and MSH2 variants using bioinformatic prediction, splicing assays, segregation, and tumor characteristicsSven Arnold, Daniel D Buchanan, Melissa Barker, et al.
Gynecologic Oncology|December 11, 2012
High-throughput interrogation of PIK3CA, PTEN, KRAS, FBXW7 and TP53 mutations in primary endometrial carcinomaDiego A Garcia-Dios, Diether Lambrechts, Lieve Coenegrachts, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 21, 2005
Common polymorphisms in ERCC2 (Xeroderma pigmentosum D) are not associated with breast cancer riskBettina Kuschel, Georgia Chenevix-Trench, Amanda B Spurdle, et al.
Breast Cancer Research : BCR|November 27, 2007
Identification of BRCA1 missense substitutions that confer partial functional activity: potential moderate risk variants?Paul K Lovelock, Amanda B Spurdle, Myth T S Mok, et al.
Gynecologic Oncology|August 21, 2017
Family history of cancer predicts endometrial cancer risk independently of Lynch Syndrome: Implications for genetic counsellingSharon E Johnatty, Yen Y Tan, Daniel D Buchanan, et al.
Plos One|March 18, 2025
A Swedish genome-wide haplotype association analysis identifies novel candidate loci associated with endometrial cancer riskElin Barnekow, Wen Liu, Emil Andersson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 19, 2007
Association between single-nucleotide polymorphisms in hormone metabolism and DNA repair genes and epithelial ovarian cancer: results from two Australian studies and an additional validation setJonathan Beesley, Susan J Jordan, Amanda B Spurdle, et al.
Pageof 40